MEDOXY

Active

Private limited companyfounded 20224 yrs activeRue des Bouvreuils(N) 10, 4121 Neupré, BelgiumKBO/BCE: BE 0790.403.510

Summary

The computed 12-month bankruptcy probability of MEDOXY is 2.8% (moderate). The 2025 annual accounts show equity of €108,773 and a net result of €12,462. Equity is growing by ~34.8% per year across the filed fiscal years. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch Report Compare

MEDOXYActiveChecked score 58/100

Risk analysis Report Compare

What they do

Activity not known1 site

How big

€465,831total assets 2025

Equity: €108,773
Profit: €12,462

Turnover not published (abridged schema)

Financially healthy?

58 Fair Checked score 2025

Bankruptcy chance 12 m: 2.8%

Who decides

Accounts filed 26 d late0 of 1 deed read

Why 58- Limited track record- No NACE activity registered- Higher-failure-rate region+ Annual accounts: healthy financial profileFiled after the deadlineShow the evidence

Checked score

Score 2025

58 / 100

Fair

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability72▼-28

Solvency48▼-52

Growth52▼-26

Track record94

Bankruptcy probability, 12 months

2.8% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €6,000 at 30 days acceptable

Liquidity ample (current ratio 1.51 against 6.03 in 2024; short-term debt: 11.4% and cash: 15.1% of total assets), but 76.6% of the assets are financed with debt.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

No NACE activity registered

No NACE activity is registered in the KBO, which is more common among companies that later fail.

KBO · activities

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

23.4%

Return on assets

2.7%

Age of the figures

9 mo

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 4 filings

Deviation from the deadline

2025

26 d late

2024

59 d early

2023

182 d late

2022

15 d late

← before the deadline after the deadline →

tick = median of all Belgian filings

This company filed its last 4 accounts on average 41 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 21 August (3 of the last 4 filed years within 80 days of that day).

Companies Code · seven months

Position in the running window

01-10-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage